![Theranos’ Holmes Won’t Avoid Jail While Her Appeal Is Pending](https://www.g2intelligence.com/wp-content/uploads/2023/04/Apr12-2023.News_.HolmesAppeal-iStock-487297776_1100x800-1080x675.jpg)
Theranos’ Holmes Won’t Avoid Jail While Her Appeal Is Pending
On Monday, federal Judge Edward Davila denied the disgraced Theranos CEO’s motion to remain free while she appeals her conviction.
On Monday, federal Judge Edward Davila denied the disgraced Theranos CEO’s motion to remain free while she appeals her conviction.
The bipartisan bill was recently reintroduced to amend the FCA in response to a landmark 2016 Supreme Court ruling.
A recent study revealed burnout rates of 49.9 percent among healthcare professionals during the early stages of the COVID-19 pandemic.
Our June virtual event will offer a variety of solutions and strategies for dealing with key issues labs face during times of economic strife.
New legislation would force CMS to change the way it calculates Medicare prices for lab tests.
On Friday, the US federal trade commission ordered Illumina to divest Grail, which it acquired for $8 billion in August 2021.
Last week saw three key settlements, including a lab accused of paying kickbacks for test referrals and billing for unnecessary drug tests.
The U.S. Department of Justice recently announced inflationary increases to civil monetary penalties under the False Claims Act.
No company better embodies the vicissitudes of running a COVID-19-focused diagnostics business during the pandemic period than Lucira Health.
HHS secretary takes action to ensure that EUAs remain in effect until the “significant potential” for a COVID-19 PHE no longer exists.